tiprankstipranks
LSL Pharma Group Inc (TSE:LSL)
:LSL
Canadian Market

LSL Pharma Group Inc (LSL) Income Statement

Compare
2 Followers

LSL Pharma Group Inc Income Statement

Last quarter (Q3 2024), LSL Pharma Group Inc's total revenue was $―, a decrease of ― from the same quarter last year. In Q3, LSL Pharma Group Inc's net income was $-386.00K. See LSL Pharma Group Inc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Jul 22Dec 21Dec 20Sep 20
Total Revenue
$ ―$ ―$ ―$ ―$ ―
Gross Profit
$ 1.65M$ ―$ 2.53M$ 943.03K$ 507.58K
Operating Expenses
$ ―$ ―$ ―$ ―$ ―
Depreciation and Amortization
$ ―$ ―$ ―$ ―$ ―
EBITDA
$ -5.77M$ -70.85K$ 931.55K$ 747.58K$ 990.62K
Operating Income
$ -6.67M$ -70.85K$ -65.27K$ 564.05K$ 809.27K
Other Income/Expenses
$ ―$ ―$ ―$ ―$ ―
Pretax Income
$ ―$ ―$ ―$ ―$ ―
Net Income
$ -8.47M$ -74.22K$ -1.78M$ 152.47K$ 88.01K
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ ―$ ―$ ―$ ―$ ―
Diluted EPS
$ ―$ ―$ ―$ ―$ ―
Weighted Average Shares Outstanding
Weighted Average Shares Outstanding (Diluted)
Currency in USD

LSL Pharma Group Inc Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis